The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer

NCT01268163 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: European Taxotere®
DRUG: American Taxotere®
DRUG: Hospira Docetaxel Injection

Sponsor

Hospira, now a wholly owned subsidiary of Pfizer